NUS — Nu Skin Enterprises, Inc.

Nu Skin Enterprises (NUS) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $320.6 million, within guidance, with a 1% favorable foreign currency impact.
• GAAP EPS: $0.04; Adjusted EPS: $0.14, aligning with guidance.
• Adjusted Gross Margin: 67.9%, slightly up from 67.8% year-over-year; core business gross margin improved to 76.9%.
• Selling Expense: 34.3% of revenue, up from 32.5% in the prior year, reflecting investments in sales leader compensation.
• General and Administrative Expenses: Decreased by $9 million year-over-year; G&A as a percentage of revenue increased to 29.9%.
• Adjusted Operating Margin: 3.6%, down from 6.4% in the prior year.
• Shareholder Returns: Approximately $8 million returned, including $3 million in dividends and $5 million in share repurchases.

2. Strategic Updates and Business Highlights:

• Continued development of the Prysm iO platform, aimed at enhancing customer engagement through personalized wellness assessments.
• Positive trends in Latin America and Mainland China, with improved sales leader engagement and product rollouts.
• Focus on expanding into emerging markets like India, with preparations for a formal launch by year-end 2026.
• Emphasis on operational efficiency and gross margin improvement through localized manufacturing and strategic pricing.

3. Forward Guidance and Outlook:

• Q2 2026 Revenue Guidance: Expected between $330 million to $360 million, indicating sequential improvement.
• Q2 2026 EPS Guidance: Anticipated in the range of $0.15 to $0.25.
• Maintained annual guidance with a cautious outlook due to macroeconomic pressures.

4. Bad News, Challenges, or Points of Concern:

• Macro Headwinds: Ongoing inflationary pressures, rising fuel costs, and geopolitical dynamics are straining consumer sentiment and purchasing power.
• Adjusted Operating Margin Decline: Down from the previous year, indicating challenges in cost management amidst investment in growth initiatives.
• Selling Expense Increase: Higher selling expenses may impact profitability if not managed effectively.
• Emerging Market Risks: The Indian market, while promising, requires careful execution and understanding of local consumer behavior, with limited revenue expected initially.

5. Notable Q&A Insights:

• Prysm iO Training: Successful leaders are utilizing Prysm as a consultative wellness tool; training focuses on product knowledge and consumer engagement strategies.
• India Market Strategy: Nu Skin is taking a cautious approach to entering India, emphasizing the importance of understanding local consumer dynamics before a full-scale launch.
• Consumer Sentiment Impact: Management is closely monitoring macroeconomic factors affecting consumer spending, with a focus on delivering value through innovation.
• Capital Allocation Priorities: Continued focus on funding strategic growth initiatives while maintaining a strong liquidity profile and considering shareholder returns through dividends and share repurchases.

Overall, Nu Skin reported steady performance in Q1 2026, with strategic initiatives underway to drive future growth, albeit facing significant macroeconomic challenges.